Location History:
- Basel, CH (2011)
- Allschwil, CH (2015)
Company Filing History:
Years Active: 2011-2015
Title: The Innovations of Stephan Buchmann
Introduction
Stephan Buchmann is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding 2 patents that focus on innovative compounds and their applications. His work is characterized by a commitment to improving vascular function and developing neurohormonal antagonists.
Latest Patents
Buchmann's latest patents include the invention of crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-o-tolyl-thiazolidin-4-one. This invention relates to processes for the preparation of these crystalline forms, pharmaceutical compositions containing them, and their use as compounds that improve vascular function and act as immunomodulating agents. Another significant patent is for 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as a crystalline sulfate salt. This invention details a process for its preparation and its use in pharmaceutical formulations.
Career Highlights
Buchmann is currently associated with Actelion Pharmaceuticals Ltd, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic agents that address critical health issues.
Collaborations
Some of his notable coworkers include Nicholas Bonham and Alex Eberlin, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Stephan Buchmann's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the development of new therapeutic agents that can improve health outcomes.